Condition: Chronic Inducible Urticaria · Chronic Spontaneous Urticaria · Sponsor: Enanta Pharmaceuticals, Inc
This study is a randomized, double-blind, sponsor-open, placebo-controlled study. It will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered single and multiple doses of EDP-978 in healthy adult subjects.
This description comes directly from the study's public registry record.
Enanta Pharmaceuticals, Inc · (617) 607-0800 · emartin@enanta.com
Always discuss trial participation with your own doctor first.
| ICON Early Phase | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07540910